Stock Information

• Tempus AI Expands Strategic Partnership Amid Oncology Boom
  Thu, Apr 16, 2026 4:52 PM
• DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
  Thu, Apr 16, 2026 1:15 PM
• Illumina Unveils DRAGEN v4.5 Software To Help Genomic Researchers Reduce Noise, Improve Accuracy And Extract Biological Signals
  Thu, Apr 16, 2026 9:20 AM
• Illumina Introduces DRAGEN Version 4.5 Software
  Thu, Apr 16, 2026 9:19 AM
• Illumina’s Pediatric Genomics Push Tests Long Term Growth Narrative
  Wed, Apr 15, 2026 3:07 AM
• Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
  Tue, Apr 14, 2026 1:15 PM
• Illumina and the Center for Data-Driven Discovery in Biomedicine Enter Data Partnership to Advance Research in Pediatric Cancer and Rare Disease
  Tue, Apr 14, 2026 1:05 PM
• Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform
  Tue, Apr 14, 2026 12:03 PM
• Illumina Enters Data Partnership With The Center For Data-Driven Discovery In Biomedicine To Advance Research In Pediatric Cancer And Rare Disease
  Tue, Apr 14, 2026 9:21 AM
• Three Best Genomics Stocks for Your Portfolio in 2026
  Mon, Apr 13, 2026 2:19 PM

Financial data not available